No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
CN Stock MarketDetailed Quotes
688198 Beijing Balance Medical Technology Co., Ltd.
- 106.27
- -0.68-0.64%
Trading Jan 7 13:19 CST
14.60BMarket Cap140.94P/E (TTM)
107.55High105.60Low656.55lotVolume106.89Open106.95Pre Close7.01MTurnover0.05%Turnover Ratio126.66P/E (Static)137.40MShares166.0052wk High12.46P/B14.60BFloat Cap92.5552wk Low128.34Limit Up137.40MShs Float234.06Historical High85.56Limit Down1.82%Amplitude20.20Historical Low0.80Dividend TTM106.76Avg Price311.80lotAsk0.75%Div YieldTTM100Lot Size298.36lotBid
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Beijing Balance Medical Technology's Medical Device Enters Special Review Procedure
Express News | Beijing Balance Medical Technology Co., Ltd.: The self-developed interventional pulmonary valve and delivery system has entered the special review process for innovative medical instruments.
Beijing Balance Medical Technology Co., Ltd. (688198.SH): The application for the registration of ophthalmic biological patches has been accepted.
beijing balance medical technology co., ltd. (688198.SH) announced that recently, the company's registration application for ophthalmic biological patch products developed by the company has been approved...
Express News | beijing balance medical technology co., ltd.: The registration application of ophthalmic biological patch has been accepted.
Beijing Balance Medical Technology Co., Ltd. (688198.SH): Application for pericardial membrane registration has been accepted.
GeLongHui, November 19th | Beijing Balance Medical Technology Co., Ltd. (688198.SH) announced that the registration application for the pericardium (ePTFE) developed by the company has been officially accepted by the National Medical Products Administration. The product is a porous polytetrafluoroethylene (ePTFE) membrane processed and manufactured through special techniques, used for repairing or reconstructing the pericardium in cardiac surgery.
Deep * company * beijing balance medical technology co., ltd. (688198): stable growth on the revenue side, bullish on the future performance increment of new products.
The company released the third quarter report for 2024, realizing a year-on-year revenue growth of 13.57% in the first three quarters of 2024, while the net income attributable to shareholders decreased by 16.56% year-on-year, putting pressure on the profit end. The company continues to increase its research and development investment.